Katsuaki Maehara

Katsuaki Maehara: Summary of Major Clinical Trials of ICI’s in Early Stage NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:

”Summary of Major Clinical Trials of Immune Checkpoint Inhibitors (ICI’s) in Early Stage NSCLC. As of September 2024.

Study design.

Katsuaki Maehara

Key Clinical Data.”

Katsuaki Maehara

Source: Katsuaki Maehara/X

cancer clinical trial Katsuaki Maehara Lung cancer NSCLC OncoDaily Oncology